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Research
Predicting the virulence of MRSA from its genome
sequence
Maisem Laabei,1,11 Mario Recker,2,11 Justine K. Rudkin,1 Mona Aldeljawi,1
Zeynep Gulay,3 Tim J. Sloan,4 Paul Williams,4 Jennifer L. Endres,5 Kenneth W. Bayles,5
Paul D. Fey,5 Vijaya Kumar Yajjala,5 Todd Widhelm,5 Erica Hawkins,1 Katie Lewis,1
Sara Parfett,1 Lucy Scowen,1 Sharon J. Peacock,6 Matthew Holden,7 Daniel Wilson,8
Timothy D. Read,9 Jean van den Elsen,1 Nicholas K. Priest,1 Edward J. Feil,1
Laurence D. Hurst,1 Elisabet Josefsson,10 and Ruth C. Massey1,12
1Department of Biology and Biochemistry, University of Bath, Bath BA2 7AY, United Kingdom; 2College of Engineering, Mathematics &
Physical Sciences, University of Exeter, Exeter EX4 4QF, United Kingdom; 3Department of Clinical Microbiology, School of Medicine,
Dokuz Eylul University, 35210 Konak, Turkey; 4Centre for Biomolecular Sciences, University of Nottingham, Nottingham NG7 2RD,
United Kingdom; 5Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska 68198-5900,
USA; 6Department of Medicine, University of Cambridge, Addenbrooke’s Hospital, Cambridge CB2 0QQ, United Kingdom; 7The Wellcome
Trust Sanger Institute, Cambridge CB10 1SA, United Kingdom; 8Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN,
United Kingdom; 9Department of Human Genetics, Emory University, Atlanta, Georgia 30322, USA; 10Department of Rheumatology
and Inflammation Research, University of Gothenburg, 405 30 Gothenburg, Sweden
Microbial virulence is a complex and often multifactorial phenotype, intricately linked to a pathogen’s evolutionary tra-
jectory. Toxicity, the ability to destroy host cell membranes, and adhesion, the ability to adhere to human tissues, are the
major virulence factors of many bacterial pathogens, including Staphylococcus aureus. Here, we assayed the toxicity and ad-
hesiveness of 90 MRSA (methicillin resistant S. aureus) isolates and found that while there was remarkably little variation in
adhesion, toxicity varied by over an order of magnitude between isolates, suggesting different evolutionary selection
pressures acting on these two traits. We performed a genome-wide association study (GWAS) and identified a large number
of loci, as well as a putative network of epistatically interacting loci, that significantly associated with toxicity. Despite this
apparent complexity in toxicity regulation, a predictive model based on a set of significant single nucleotide polymorphisms
(SNPs) and insertion and deletions events (indels) showed a high degree of accuracy in predicting an isolate’s toxicity solely
from the genetic signature at these sites.Our results thus highlight the potential of using sequence data to determine clinically
relevant parameters and have further implications for understanding the microbial virulence of this opportunistic pathogen.
[Supplemental material is available for this article.]
A key factor affecting the severity and outcome of any infection
is the virulence potential of the infecting organism. If the viru-
lence phenotype could be determined directly from its genome
sequence, next generation sequencing technology would provide
for the first time an opportunity tomake predictions of virulence at
an early stage of infection. Since the first whole genome sequence
of a free-living organism, Haemophilus influenzae, was published
(Fleischmann et al. 1995) sequencing technology has advanced to
a stage where a bacterial genome can be sequenced in a matter of
hours (Parkhill and Wren 2011; Didelot et al. 2012a; Eyre et al.
2012; Ko¨ser et al. 2012a). This has led to an explosion of genomic
data that has allowed us to monitor outbreaks in hospitals (Ko¨ser
et al. 2012b; Young et al. 2012; Harris et al. 2013; Sherry et al.
2013; Walker et al. 2013), track strains transitioning from carrier
to invasive status (Young et al. 2012), and perform detailed epi-
demiological studies to understand aspects of pathogen biology
(Castillo-Ramı´rez et al. 2011, 2012; Didelot et al. 2012b; McAdam
et al. 2012; Holden et al. 2013). While some success has also been
made in predicting phenotype from genotype, such as the anti-
microbial resistance (Farhat et al. 2013; Holden et al. 2013),
for more complex phenotypes, such as virulence, involving the
contribution of several genes, this has not yet been possible.
Furthermore, complex interactions between genes (epistasis) are
not apparent from genome sequences alone, nor is the effect of
epigenetics (Borrell and Gagneux 2011; Jelier et al. 2011; Beltrao
et al. 2012; Bierne et al. 2012).
Staphylococcus aureus is a major human pathogen, the treat-
ment of which has been complicated by the worldwide emergence
of multiple lineages that have acquired resistance to methicillin
(methicillin resistant S. aureus, MRSA) (Lowy 1998; Gordon and
Lowy 2008; Otto 2010). Its virulence is conferred by the activity
of many effector molecules which can be broadly grouped into
being either toxins (Lowy 1998; Gordon and Lowy 2008; Otto
2010)—factors that cause specific tissue damage in the host, or
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adhesins—factors that facilitate adherence to and invasion of host
tissues (Foster et al. 2014). The ability of toxins to lyse human cells
causes local tissue damage, facilitating immune evasion, release of
nutrients, dissemination within a host, and transmission to others
(Lowy 1998; Gordon and Lowy 2008; Otto 2010). A complex net-
work of regulatory proteins controls the expression of many in-
dividual toxins (Priest et al. 2012), such that various sites on the S.
aureus chromosome contribute to the overall toxicity of an in-
dividual isolate. The ability of S. aureus cells to bind human gly-
coproteins, such as fibrinogen and fibronectin, is another critical
determinant in disease outcome. It facilitates attachment to and
damage of host tissues, host cell invasion, and systemic dissemi-
nation (Foster et al. 2014). Several genes encode fibronectin- and
fibrinogen-binding proteins (e.g., fnbA, fnbB, clfA, clfB, eap, isdA,
emp, ebh, etc.), whose expression is again controlled by a complex
regulatory network (Priest et al. 2012). Similar to toxicity, many
sites on the chromosome can therefore contribute to the overall
adhesiveness of S. aureus, with many regulators common to both
adhesion and toxicity (Priest et al. 2012).
The success of epidemic MRSA clones such as USA300 and
sequence type (ST) 239 is attributed to a variation in their expres-
sion of either toxins or adhesins (Li et al. 2010; Otto 2010; Li et al.
2012). In response to the prevalence of the highly toxic USA300
clone, guidelines exist that recommend treating suspected
infections with vancomycin and a second antibiotic such as
clindamycin or linezolid to reduce toxin expression and the asso-
ciated disease severity (http://www.hpa.org.uk/webc/HPAwebFile/
HPAweb_C/1242630044068). It is therefore clear that the ability to
predict whether an infecting isolate is either highly adhesive or
highly toxic could allow clinicians to adapt treatment approaches
and increase their index of suspicion for disease complications for
infected individuals.
To address this, we adopted a genome-wide association study
(GWAS) and a machine learning approach to determine the fea-
sibility of predicting virulence from the genome sequences of
90 MRSA isolates. Our findings demonstrate that using whole-
genome sequence data for large collections of isolates to identify
genetic signature associatedwith a specific trait can be used to infer
complex phenotypes from genotype.
Results
Toxicity varies more than adhesiveness between S. aureus
isolates
We first assayed the ability of 90 independent ST239 isolates (listed
in Supplemental Table 1) to bind fibrinogen and fibronectin in
both exponential and stationary phase of growth, as this varies
and is believed to reflect different stages of infection. As expected,
adhesiveness for all isolates was higher in exponential than sta-
tionary phase (Supplemental Fig. 1A–D). However, across the 90
isolates only two differed significantly from the others, being
higher in both growth phases. The limited variability of this vir-
ulence phenotype suggests it may be under strong purifying se-
lection and would provide limited information on which to base
a prediction of disease severity.
We next measured the gross lytic activity of these isolates
using an immortalized T-cell line (Collins et al. 2008; Rudkin et al.
2012) (sensitive to beta toxin, gamma toxin, delta toxin, LukED
and PSMalpha1, alpha2 and alpha3) and lipid vesicles (Laabei et al.
2012) (sensitive to delta toxin and PSMalpha1, alpha2 and al-
pha3). No differences in lytic abilities were observed across these
two assays (Supplemental Fig. 2), suggesting the effect is either
largely PSM driven for the ST239 clone, or that the toxins assayed
here are co-regulated. We also measured the expression of alpha
toxin, as these lytic systems are not sensitive to this toxin’s activity,
but no variation across the isolates was observed (Supplemental
Fig. 3). However, the combined activity of the other toxins varied
widely between the 90 isolates, with an 18-fold difference be-
tween the most and least toxic isolates (Fig. 1A). Interestingly,
both the highly adhesive isolates identified above expressed low-
level toxicity. (NB: This clone does not contain the Panton-
Valentine leukocidin [PVL] containing phage [Castillo-Ramı´rez
et al. 2012].)
To understand how differences in toxicity are distributed
across the genetic variability that exists within this collection of
isolates we divided the data into three classes, scoring isolates as
expressing either high (red: levels of >63,000 units), medium
(amber: levels of 30,000:63,000 units) or low (green: levels of
<30,000 units) toxicity. These three data ranges were selected so
that a mid-toxicity range was included to account for possible
cumulative effects of genetic polymorphisms. This was mapped
onto a maximum likelihood tree based on the genome sequences
of these isolates, showing a broad distribution of toxicity pheno-
types across the genotypes as well as some clustering (Fig. 1B).
Toxicity correlates with disease severity in vivo
To verify that toxicity correlated with disease severity, two isolates
shown to have the highest and the lowest levels of toxicity in vitro
(HU13 and MU9, respectively) were selected and their in vivo
pathogenicity compared in amodel of invasive infection (Josefsson
et al. 2008; Kenny et al. 2009). Mice were injected intravenously
with two different inoculum sizes; and murine survival, the de-
velopment of septic arthritis, and weight loss weremonitored over
two weeks as a measure of disease severity (Josefsson et al. 2008;
Kenny et al. 2009). Uninfected control mice did not die, did not
develop septic arthritis, and did not lose weight over the duration
of this experiment. In each aspect of disease measured here, the
highly toxic HU13 isolate caused the most severe disease symp-
toms (Figs. 2A–F). It led tomore deaths at both doses, although this
was not statistically significant, caused significantly more severe
arthritis at both doses at day 4, and resulted in significantly greater
weight loss at both doses across many time points.
The isolates tested here are from the same sequence type but
are not isogenic, and so other virulence-related traits may have
played a role in the disease outcome. However, as toxicity is well
established to affect disease severity, its variability evenwithin this
closely related group of isolates suggests that the ability to predict
toxicity at an early stage of infection would be valuable clinical
information.
Identifying virulence-associated loci
We first employed a GWAS on the genomes of these 90 S. aureus
isolates to identify the genetic polymorphisms that associatedwith
the toxic phenotype. Out of a total of 3060 SNPs, we identified
100 that associated significantly with toxicity (with P < 0.05 after
correction for genomic inflation [Supplemental Fig. 4; Supple-
mental Tables 2A,B], using a frequency cutoff for the occurrence
of a polymorphism [i.e., successfully genotyped] across the pop-
ulation of >90% and a minor allele frequency of >5%). We further
identified 22 toxicity-associated indels, using the same cutoffs for
quality control. To test the effect of population structuring we used
2 Genome Research
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a hierarchical clustering algorithm (pvclust) in R, which showed
strong bootstrap support for three main clusters (Supplemental
Fig. 5), two of which contained all the highly toxic strains. We
then performed a permutation procedure in PLINK, correcting
for cluster membership, to obtain empirical P-values. Out of the
122 polymorphisms previously identified, only one (snp1360889)
fell out using this procedure. Unfortu-
nately, the limited sample size prevented
us from using a more detailed clustering
approach.
These SNPs and indels were distrib-
uted across the genome amongst mobile
genetic elements, genes involved in me-
tabolism and regulation, in hypothetical
genes, and in intergenic regions. Two
genes previously shown to affect the
expression of toxins contained signifi-
cantly associated SNPs:mecA (Rudkin et al.
2012) and agrC (Ji et al. 1995; Novick and
Geisinger 2008), which provided some
proof of principle for the validity of our
approach. Mobile genetic elements, such
as the S. aureus pathogenicity Island I
(SaPI1) (Ruzin et al. 2001) and the beta-
haemolytic converting phage (Bae et al.
2006), also contained several associated
genetic changes, implying that variabil-
ity in many diverse regions of the genome
contributes to the toxicity of a given iso-
late. Someof the polymorphisms appeared
to be in linkage disequilibrium (Supple-
mental Fig. 6A), which will increase the
rate of false positive associations, butmany
were uniquely occurring (i.e., unique pat-
terns of polymorphisms across isolates)
(Supplemental Fig. 6B).
This GWAS approach requires no
evidence of repeatability of a signal, just
an excess association between a SNP and
the phenotype in question, and as such is
likely to produce false positives with
linkage disequilibrium and phylogenetic
structure affecting the outcome. We there-
fore performed a second, more stringent
approach, similar to those described in
other recent work (Farhat et al. 2013;
Sheppard et al. 2013), which instead re-
quires repeatable independent evolution
of a marker to be associated with the
phenotype (toxicity). Although this ap-
proach should have a lower false positive
rate, it is likely to produce a higher false
negative rate. We focused on four clus-
ters of isolates (indicated on Fig. 1B):
cluster 1 (isolates IU20–IU2), cluster 2
(isolates HU16–HU13), cluster 3 (isolates
MU2–IU7), and cluster 4 (isolates DEU3–
DEU19). Clusters 1 and 2 contained the
majority of the highly toxic isolates in
this study, whereas clusters 3 and 4 rep-
resent the closest related clusters of low
toxicity isolates to clusters 1 and 2.Where
toxicity-associated polymorphisms are found in both clusters 1 and
2 but are absent from clusters 3 and 4 suggests that they have arisen
independently. As such they are likely to be causative as they are
independent of phylogeny. Of the 121 polymorphic sites that asso-
ciated significantly with toxicity, only four were found in both high-
toxicity clusters (1 and 2) but not in their sister, low-toxicity clusters
Figure 1. Toxic activity of clinical ST239 isolates. (A) The toxic activity of 90 ST239 isolates was
assayed by incubating their supernatants with lipid vesicles containing a fluorescent dye. Dye release
due to toxin-mediated vesicle lysis is determined using a fluorometer. (B) A maximum likelihood tree
based on whole-genome sequences of the 90 isolates illustrating the distribution of the toxic activities of
each isolate. Toxicity has been color-coded (red for highly lytic, yellow/amber for moderately lytic, and
green for low level lysis). Clusters 1–4 are indicated for use in the stringent GWAS analysis.
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(3 and4). All four of these polymorphisms (SNPs 78396, 2128192 and
indels 2111134 and 2147199, see Supplemental Tables 2, 3) reside on
mobile genetic elements, suggesting they may have been acquired
horizontally. Of these four polymorphic loci, the mecA gene (in
which SNP78396 resides) confers methicillin resistance and has pre-
viously been shown to affect toxin expression (Rudkin et al. 2012).
Functional verification of effect of polymorphisms on toxicity
With the initial GWAS approach likely to produce a high number
of false positive associations, we sought to obtain an estimate of
this by determining the functional effect of a subset of these
polymorphisms. We focused on 13 of the intergenic poly-
morphisms that could either affect the transcription of neighbor-
ing genes, or encode novel regulatory RNAmolecules.We obtained
transposon insertions in these polymorphic loci, ranging from 10
to 304 bp distal to the polymorphic site, and determined the effect
of this insertion on the toxicity of the mutant. Four of the 13 in-
sertions affected toxicity (Fig. 3) verifying that these loci contain
toxicity-regulating activity. The SNP at position 301,089 (repre-
sented by the transposon insertion in strain 95E07 in Fig. 3) is in
Figure 2. Predicted toxicity correlates with disease severity in vivo. Using high and low doses (7.8–8.0 and 3.7–4.13 107 CFU, respectively), mice were
inoculated intravenously with the high and low toxic isolates (HU13 and MU9, respectively), and survival of the mice, the development of septic arthritis,
and weight loss were recorded as indications of disease severity. In each case the highly toxic HU13 isolate caused the most severe disease symptoms. (A)
n = 10–15. (B) n = 8–10. (C ) n = 10–20. (D) n = 10. (E) n = 10–19. (F) n = 10. Significant P-values (<0.05) are indicated (*).
Laabei et al.
4 Genome Research
www.genome.org
 Cold Spring Harbor Laboratory Press on May 7, 2014 - Published by genome.cshlp.orgDownloaded from 
between the tarK and tarF genes that are involved in the synthe-
sis of wall teichoic acids (Qian et al. 2006). The SNP at position
1,121,452 (represented by the transposon insertion in strain
207A03 in Fig. 3) is between a hypothetical gene and fmt, which is
involved in methicillin resistance and autolysis (Komatsuzawa
et al. 1997), both activities known to contribute to staphylococ-
cal virulence. The SNP at position 1,503,110 (represented by the
transposon insertion in strain 90D01 in Fig. 3) is in a locus anno-
tated as a pseudogene in TW20, but as intergenic between genes
encoding a TelA-like protein and a putative branched-chain amino
acid transporter protein in FPR3757. The SNP at position 2,532,617
(represented by the transposon insertion in strain 108B09 in Fig. 3)
is annotated in FPR3757 as intergenic between a hypothetical and
an AcrB/AcrD/AcrF family protein-encoding gene; however, in
TW20 it has been annotated as a hypothetical gene. Further mo-
lecular characterization is underway to determine the activity of
these loci, but this work demonstrates that although this approach
produces false positive associations, having looked at only 13 poly-
morphisms it has identified four novel toxicity-affecting loci.
As the more stringent approach described above yielded
a shortlist of only four toxicity-affecting polymorphisms, we also
sought to determine whether this approach, while reducing the
false positive rate, would inadvertently dismiss potentially impor-
tant loci. For example, a SNP in the agrC gene was identified by the
initial approach as significantly associated with toxicity, but dis-
missed by the secondary more stringent approach. This protein
forms part of a critical toxin regulatory system, and the SNP results
in an A343Tchange to the amino acid sequence of the protein. The
agr locus encodes a classical two-component regulatory system
that allows the bacterium to regulate toxicity and adhesion through
quorum sensing, in response to local cell density (Ji et al. 1995;
Novick and Geisinger 2008). The AgrC protein is responsible for
detecting the secreted autoinducing peptide (AIP) and transmits the
signal to AgrA through phosphorylation. The phosphorylated form
of AgrA acts as a transcriptional regulator at the agrP3 promoter of
the Agr system, which drives the transcription of RNAIII, a regu-
latory RNA molecule, responsible for the regulatory changes that
occur in response to the bacterial cells reaching a threshold density
(Ji et al. 1995; Novick and Geisinger 2008). As such, this is a highly
plausible candidate polymorphism that would have been disre-
garded by a more stringent approach.
The particular nucleotide change described here had not been
identified previously, although other polymorphisms in the agrC
gene have been shown to delay activation of the Agr system and
as a consequence reduced the toxicity (Traber et al. 2008). Using
a reporter system we evaluated the impact of SNP2174068 on the
function of AgrC with respect to activation by exogenous AIP
(Jensen et al. 2008). We compared the response of AgrC from the
ST239 isolate TW20 with the AgrC encoded by the SNP2174068
containing agrC variant, by determining the half maximal effec-
tive concentration (EC50) of exogeneous synthetic AIP-1 for both
(Fig. 4). The EC50 for the TW20 allele was 17.4 6 3.5 nM, but al-
most twice as much AIP (29.5 6 3.1 nM) was needed for the
SNP2174068 containing AgrC variant, which suggests that, like
previously identified polymorphisms in agrC, SNP2174068 delays
the activation of the Agr system and as a consequence reduces
toxicity. This work functionally verified the contribution of this
particular polymorphism to the toxic phenotype, which would
have been disregarded by the more stringent approach.
Identifying epistatic interactions associated with toxicity
Genes and their protein products rarely act independently, with
transcriptional, translational, post-translational regulators, and
protein:protein interactions all playing a role in their activity. As
a further hypothesis-generating exercise, we performed a pairwise
test for toxicity-associated epistatic interactions on all combina-
tions of SNPs and indels. A heat-map representing the genetic loci
predicted to interact to affect toxicity is shown in Figure 5 (P < 13
106), where the size and color of each circle correspond to the
statistical significance of the interaction, and in tabular form in
Supplemental Table 3. Many of the interactions fell on straight
lines, suggesting that a small number of genetic loci containing
SNPs may be interacting with numerous other loci. From these we
identified five genes that interacted with more than 20 other loci
with high statistical significance: the ileS gene encoding isoleucyl-
tRNA synthetase (Hurdle et al. 2004); the mreC gene involved in
Figure 3. Functional verification using transposon mutagenesis. Mu-
tated S. aureus isolates with transposon insertions in 15 of the 124 toxicity-
associated loci were isolated (all in intergenic loci). Four of the 15 trans-
poson insertions affected the toxicity of the isolate. The bars represent the
mean % T-cell survival following incubation with bacterial supernatant,
and the error bars the 95% confident intervals. Wild type represents the
unmutated parent isolate, AgrB is a negative control, and the following
are the transposon insertion mutants and their associated polymorphism:
95E07: 301089; 93B09: 761112; 82B04: 787629; 180A03: 799276;
207A03: 1121452; 90D01: 1503110; 137C12: 1931155; 45D06:
2027204; 179E03: 211134; 108B09: 2532617; 113D01: 2571739;
86C03: 2640325; 168E05: 2657438; 72A04: 2753734; 64A09: 2810368.
Figure 4. SNP2174068 has a major impact on the response of AgrC to
AIP and hence toxicity. Dose-response curves for the activation of the lux-
based agrP3 reporter via AIP-1 by the TW20 agrC allele (•) comparedwith
the SNP2174068 variant (j).
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cell wall synthesis (Kyburz et al. 2010); an uncharacterized gene on
the beta-haemolytic converting phage (Bae et al. 2006); the phy-
toene dehydrogenase gene, which is a key enzyme in the caroten-
oid biosynthetic pathway (Mijts et al. 2005); and a small, putative,
regulatory RNA molecule (ssr100) (Anderson et al. 2006). Inter-
estingly, the SNP in ileS has been shown previously to be re-
sponsible for conferring mupirocin resistance [V(588)F] (Hurdle
et al. 2004), suggesting this may have pleiotropic effects on gene
expression. The analysis also suggested that these loci also interact
with one another, forming a novel and highly variable toxicity-
regulating network.
However, caution must be exercised when interpreting these
findings. As noted above, this approach is likely to produce a high
number of false positives, and linkage between the SNPs that ap-
pear to be interacting with a single locus or population structure
may affect the outcome of such analysis. For example, the SNP in
ileS appears to be interacting epistatically with 30 other loci by this
analysis. Amore detailed survey of these 30 loci indicates that there
are only nine independently occurring polymorphisms,which still
suggests that ileSmay have pleiotropic effects on the expression of
other genes, but these need to be functionally verified before we
can have full confidence in this interpretation.
Predicting toxicity from genome sequence
Having identified specific genetic signatures (SNPs and indels) that
associate with toxicity, we next investigated whether these sig-
natures could be used to build a predictive model. Of the poly-
morphisms originally associated with toxicity, either directly or
through epistasis, many were not unique but in complete linkage
disequilibrium (Supplemental Fig. 4A). We therefore considered
a subset consisting of all the unique SNPs/indels and one fromeach
of the linked groups, which left 31 SNPs and 21 indels (Supple-
mental Fig. 4B). Performing a hierarchical cluster analysis on this
subset highlighted two important aspects. First, all but one of the
highly toxic strains (labeled red at the bottomof Fig. 6A) fall within
the same cluster, indicating that these signatures are not simply
based on the genetic relationship between the isolates (cf. Fig. 1B).
Second, there are a number of strains with different levels of tox-
icity but with identical SNP/indel signatures; these form individual
clusters (highlighted as red bars in the dendrogram on top of Fig.
6A) and can therefore not be resolved by a predictive model based
on these signatures alone.
To build the predictive model, we utilized a ‘‘random forest’’
machine learning algorithm (Breiman 2001; Touw et al. 2013),
which we used for both regression analysis and class prediction.
Thismethod, which creates an ensemble of decision trees and then
uses the mean for predictions, produces unbiased error estimates
without the need for cross-validation. For the class-predictive model,
we used the categories described above: low (class 1, green), me-
dium (class 2, amber), and high toxicity (class 3, red), respectively.
Using this set of SNP/indels the model showed an accuracy of
>85%, corresponding to an out-of-bag (OOB) error rate estimate
of <15%. As shown in Table 1A, the majority of low and highly
toxic strains were correctly identified by this model, whereas none
of themedium toxic oneswere predicted correctly. Thiswas further
highlightedwhen performing a regression analysis (Fig. 6B), where
toxicity could be predicted with a high degree of accuracy for most
of the low and highly toxic strains. The top 20 most important
SNPs and indels determined by this approach (in terms of their
influence on the model’s performance) are shown in Figure 6C,
details of which can be found in Supplemental Tables 2 and 3 and
are discussed later.
We further tested this method’s predictive ability by dividing
the isolates randomly into a training set and a test set comprising
60 and 30 isolates, respectively. That is, we trained a random for-
est model on a subset of isolates, which we then used to predict
the toxicity class of the remaining, and to the model unknown,
test isolates. As shown in Table 1B, all of the low and highly toxic
strains (23/23 and 4/4) were predicted correctly, whereas the
strains of medium toxicity were exclusively underestimated. Al-
though this clearly demonstrates the feasibility of our approach in
predicting toxicity from genome sequence data, even in the face of
unknowns such as epigenetic state, to be fully applicable to strains
outside this clonal/ sequence type, the model would necessarily
have to be trained on a much larger set of isolates from different
genetic backgrounds.
Discussion
The continuing emergence of drug resistantmicrobial pathogens is
an issue of global importance. Although new drugs are being de-
veloped, their widespread use quickly selects for further resistance,
which necessitates the development of approaches that allow cli-
nicians to tailor treatment to a specific patient’s needs. Genomic
data are believed to hold the key, but we do not yet have sufficient
information to know which parts of the genome to examine to
determine the best treatment strategy. While we are beginning to
understand how to determine antibiotic resistance profiles from
genome sequences, with hyper-virulent strains circulating we also
need to understand how to determine the likelihood of an in-
fecting strain to cause severe disease.
As toxicity and adhesion are key to disease outcome for
S. aureus we sought to determine their variability in a set of
90 isolates of the globally important ST239 clone, and whether
these phenotypes can be predicted from genome sequences. Ad-
hesion varied significantly in only two of the 90 isolates tested, and
so for the majority of the isolates used in this study adhesion
was entirely predictable without having to consider the genome
sequence. Toxicity however, showed much greater variability be-
tween isolates, and given its importance in disease outcome be-
came the main focus of this study.
GWAS has beenwidely used to identify genetic loci associated
with human diseases. Although phylogenetic structure may af-
fect the application of this to a prokaryotic system, GWAS is still
Figure 5. Heat-map representing interacting SNPs conveying epistasis
between SNPs that affects an isolate’s toxicity. Each SNP is represented on
both the x- and y-axes with the origin of replication based at the inter-
section of the axes (at zero). The size and color of the spot represent
the significance of the interaction between SNPs as illustrated by the
colored bar.
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Figure 6. Genetic signatures affecting the toxicity of MRSA isolates. (A) Unsupervised hierarchical clustering analysis of significant SNPs/indels affecting
toxicity in 90 isolates of the MRSA lineage ST239, color-coded (along the bottom) according to toxicity classes: low (green, <35,000), medium (orange,
<65,000), and high (red, >65,000). Where an isolate has either the reference sequence at a site or the SNP/indel is illustrated as a change in block color
across the rows. The most highly toxic strains are found to cluster together, indicating similar signatures independent of genetic background. Clusters
highlighted by red bars on top denote strains with identical SNP/indel signatures. SNPs and indels highlighted in red (on the left-hand side) are those found
to have high importance for the predictivemodel. (B) Random forest regression analysis shows a good fit between the strains’ observed level of toxicity and
those predicted by themodel; most outliers belong to clusters of identical strains, which cannot be resolved by these SNP/indel signatures. (C ) Top 20 SNP
and indels with highest influence on class prediction error, ordered by descending degree of importance.
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a useful tool to identify candidate virulence affecting loci. Bacteria
are haploid with high mutation rates, and so mutations affecting
phenotypes are immediately detectable. Additionally, bacteria read-
ily exchange DNA encoding virulence genes horizontally, and these
are independent of phylogeny.With these considerations, we used
GWAS and identified 121 genetic loci significantly associated with
changes in the toxicity of individual isolates. Some of the genes in
which this variability occurred have been identified previously as
having a role in toxicity regulation, which demonstrated the val-
idity of this approach. More importantly, it also identified a large
number of novel putative toxicity affecting loci, and a set of five
loci that appear to interact epistatically with each other and many
other loci to affect toxicity, suggesting they may form a novel
toxicity regulatory network. A more stringent approach reduced
this list down to four candidate loci, and while this is a more man-
ageable number to functionally verify, at least one functional locus
(SNP in agrC) was lost by this approach. Although one method
produced a high rate of false positives and the other dismissed po-
tentially important loci, both have proven to be informative. When
we attempted to functionally verify a subset (n = 13) from the long
list of 121 by testing transposon insertion mutants in these regions,
four proved to have toxicity regulating activity. This provided an
indication of the false positive rate associated with the initial GWAS
approach, and demonstrated that it is an effective means of priori-
tizing candidate genes for further functional characterization.
As an opportunistic pathogen S. aureus can readily transfer
from carriage to an invasive stage. It also has heterogeneity in its
ability to transmit to new hosts, asymptomatically by direct con-
tact or symptomatically through the production of pus. Adhesion
is critical to all stages and transmission strategies. Toxicity, how-
ever, is more important for disease, pus production, and symptom-
atic transmission. Highly mutable loci in bacterial genes encoding
proteins under strong immune selection are believed tohave evolved
to readily switch expression of the gene on and off, proving con-
tingency for a fluctuating environment (Moxon et al. 2006). Here,
however, we see great phenotypic diversity at the population level,
encoded by many loci, the exact number of which can only be
determined experimentally. With the relative benefit of toxicity
being contingent on its life stage, it is therefore possible that
having a complex regulatory system with many loci involved
introduces the opportunity for great variability. This increased
opportunity for variability in toxicity relative to adhesion may
contribute to the opportunistic lifestyle of S. aureus in the same
way a phenotype switch contributes at an individual level.
We adopted a machine learning approach and found that the
presence of these loci was sufficient to predict the toxicity of the
majority of isolates. This analysis also identified a list of highly
important loci (Fig. 6C), the top of which was a 1-bp deletion in an
intergenic region between the gene encoding the 16S ribosomal
subunit and perR, a transcriptional regulator known to affect vir-
ulence (Horsburgh et al. 2001). Preliminary analysis of the sequence
surrounding this site suggests it has a high level of secondary
structure in a single stranded form, and the deletion of this base
reduces this, which suggests it may be a regulatory RNA molecule,
although further molecular analysis is needed to confirm this. The
second most important site was a SNP in an uncharacterized gene
on the S. aureus pathogenicity island 1, the third is in an intergenic
region the effect of which on toxicity has been verified using
transposon mutagenesis (Fig. 3), the fourth is in an uncharac-
terized gene on the beta toxin converting phage, and fifth is the
agrC SNP characterized above. Although work to further charac-
terize these loci and the role they play in toxicity is currently un-
derway, this clearly indicates how this approach might be a useful
tool for identifying new effector loci contributing to complex
phenotypes.
The informative value of our hypothesis generating approach
also extends to the case where there was a significant deviation
between assayed toxicity and model prediction. That is, the tox-
icity of a small number of isolates was not well predicted, and we
hypothesized that this could be explained by rare gain/loss-of-
function genetic events that would not be identified using a sta-
tistical approach. A survey of all genetic changes associated with
these poorly predicted isolates reveals that DEU29, for example,
does not contain the beta-haemolytic converting phage (Bae et al.
2006). As such, unlike all the other isolates in this study, this isolate
has an intact beta-haemolysin gene, providing a plausible expla-
nation for why this is highly toxic despite being predicted as
expressing low toxicity. MU4, which has a low level toxicity but
was predicted to be highly toxic, has a unique SNP in the gene
encoding the Rot (repressor of toxins) protein, which could have
a dominant effect on toxicity (McNamara et al. 2000). The con-
tribution of each SNP and indel event described here needs to be
quantified in isogenic backgrounds, and although the scale of work
involved is currently challenging, it is becoming more feasible
with the development of high efficiency mutational protocols.
An alternative or complimentary explanation for the poor
predictability for some isolates may lie in the mapping approach
used. Illumina sequencing technology was used where the se-
quence data were mapped onto a reference genome, MRSA ST239
isolate TW20 (Holden et al. 2010). A limitation of this approach is
that DNAnot found in the reference strain is ignored, so additional
genetic elements that could affect the toxicity of these poorly
predicted isolates may not be identified. As sequencing on this
scale improves with longer, better quality reads we will be able to
perform de novo assemblies for each genome, which would allow
all DNA in an isolate to be identified and tested for associationwith
a specific trait.
It has been suggested that genome sequencing alone cannot
give sufficient information to explain or predict complex pheno-
types, as it does not consider the additional factors that affect
protein expression such as epigenetics (Borrell and Gagneux 2011;
Jelier et al. 2011; Beltrao et al. 2012; Bierne et al. 2012). However,
here we have shown that using robust statistical techniques on
large collections of sequenced isolates alongside machine learning
approaches can yield desired results. When applied to virulence,
while predicting the outcome of an infection will undoubtedly
have to take into account the health and immune status of the af-
fected host, we have described the first step toward this goal—that it
Table 1. Random forest class prediction of toxicity
(A) Fitted model based on 90 isolates
Predicted Observed Class error
Low Medium High
Low 68 0 1 0.01
Medium 9 0 0 1.00
High 3 0 9 0.25
(B) Prediction of 30 unknown strains
Low 23 0 0 0.00
Medium 3 0 0 1.00
High 0 0 4 0.00
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is possible to predict the potential of a bacterial isolate to cause
severe disease from the genome sequence alone. Further work
quantifying the effect of each SNP on toxicity, virulence, and the
expression of other virulence loci will add further detail to the
model presented here. Also required will be the identification of
more complex, three- and four-way epistatic interactions between
genes,whichwill allowus to increase themodel’s predictive power. As
the time nears when it is as cost-effective for a clinician to send
a clinical sample for genome sequencing as it is to a routine di-
agnostic lab (Parkhill and Wren 2011; Didelot et al. 2012a; Eyre
et al. 2012; Ko¨ser et al. 2012a), the next major challenge must be
to adopt approaches as described here to build appropriate tools to
convert genome sequences into information that can be used to
help improve the treatment of infected patients.
We can imagine scenarios in which a patient’s bacteria are
grown, targeted PCR, SNP arrays or rapid genome sequencing can
be performed, and the machine learning approach applied to flag
up, possiblywithin a fewhours of initial bacterial isolation,whether
the strain is likely to be toxic. The patient can then be immediately
isolated, given virulence-modulating antibiotics, and monitored
more stringently for complications. In addition to improving and
personalizing the care of patients infected with highly toxic bacte-
ria, it would also prevent the needless and deleterious administra-
tion of cocktails of potent and expensive antibiotics to patients with
low toxicity infections. The predictive model itself would require
regular updating, given all the new information. Whether there
needs to be one model per clone, or one that adequately covers all
isolates of S. aureus remains to be discovered. Either way, the ap-
proach described in this work is the first step in this direction.
Methods
Isolates and plasmids
The isolates and plasmids used in this study are listed in Supple-
mental Table 1.
Fibronectin- and fibrinogen-binding assays
Bacterial adhesion to human fibronectin (Fn) and fibrinogen
(Fb) (Sigma) was assessed using an adaptation of a previously
published protocol (Edwards et al. 2010). For stationary phase
growth, bacteria were grown for 18 h and were washed three
times in phosphate-buffered saline (PBS). Final bacterial con-
centrations were normalized to an optical density of 0.5–0.55 at
600nm, which corresponds to ;1 3 10
8 CFU/mL. Exponential
growth phase bacteria were grown for 3–4 h, with supernatant
harvested and bacterial pellet washed and normalized as above.
Adherent bacteria were calculated by using the crystal violet
method (Edwards et al. 2010) and absorbance measured at A595
using a microtitre plate reader. Absorbance measurements were
converted to bacterial numbers as described previously (Edwards
et al. 2010).
Toxicity assays
The toxicity of individual ST239 isolates was assayed in three ways.
The expression of alpha toxin was determined byWestern blotting
using TCA precipitated 18-h bacterial supernatants (Ohlsen et al.
1997). No differences in signal intensity were observed across the
90 isolates (Supplemental Fig. 2). The ability of the isolates to lyse
T cells, which measured beta toxin, gamma toxin, delta toxin,
PSMalpha1, alpha2, and alpha3 activity was performed as described
previously (Collins et al. 2008; Rudkin et al. 2012). Lipid vesicles,
which are susceptible to delta toxin, PSMalpha1, alpha2, and al-
pha3, were prepared as described previously (Laabei et al. 2012).
Briefly, vesicles for toxicity assay were composed of 25 mol%
of 10,12-Tricosadiynoic acid (TCDA), 53 mol% 1,2-dipalmitoyl-sn-
glycero-3-phosphocholine (DPPC), 2mol%1,2-dipalmitoyl-sn-glycero-
3-phosphoethanolamine (DPPE), and 20mol%of cholesterol (CHO).
Lipid films were rehydrated in 50 mM 5(6)-carboxyfluorescein (CF)
in HEPES buffer solution, freeze/thawed three times under liquid
nitrogen extruded three times through 23 0.1 mmpolycarbonate
filters under nitrogen pressure. Vesicle purification was achieved
through filtration through Nap-25 columns, stored overnight at
4°C and then cross-linked under UV for 6 sec. Toxicity assays were
performed using 18-h bacterial supernatant and pure vesicles in a
1:1 ratio and fluorescence intensity measured at excitation and
emission wavelengths of 485–520nm, respectively, on a FLUOstar
fluorometer (BMG labtech). Positive and negative controls were
pure vesicle with 0.01% Triton X-100 and HEPES buffer, re-
spectively. No difference was observed in the lytic activity of the
isolates whether vesicle or T cells were used (Supplemental Fig. 4),
so the data from the vesicles are presented and were used for
further analysis.
Maximum likelihood tree
This was estimated using PhyML with an HKY85 substitution
model, empirical nucleotide usage, no rate heterogeneity, and no
invariant sites.
GWAS
The identification of genetic variation in the clinical isolates
studied has previously been described (Castillo-Ramı´rez et al.
2012). In summary, unique index-tagged libraries for each sample
were created, and up to 12 separate libraries were sequenced in
each of eight channels in Illumina Genome Analyser GAII cells
with 75-base paired-end reads. Data have previously been de-
posited in the European Nucleotide Archive under study number
ERP000228. The paired-end reads were mapped against the chro-
mosome of S. aureus TW20 (accession number FN433596) (Holden
et al. 2010) using SMALT (http://www.sanger.ac.uk/resources/
software/smalt/) and SNPs and indels were identified as described
in Croucher et al. (2011). For each isolate the average coverage
ranged from 38- to 323-fold (stats for each isolate can be found in
Supplemental Table 1), with a mean average coverage of 127 fold.
Mobile genetic elements and accessory regions in the TW20 ref-
erence chromosome had previously been identified by manual
curation (Holden et al. 2010).
We conducted a quantitative association study on a set of 90
isolates of the S. aureus clone ST239 to identify single nucleotide
polymorphisms (SNPs) that were significantly associated with toxic-
ity, using the PLINK software package (http://pngu.mgh.harvard.edu/
purcell/plink/) (Purcell et al. 2007). From the original set of 3060
intragenic SNPswe identified 100 SNPswith statistical significance
of P < 0.05 after quality control (using PLINK options -geno 0.9 and
-maf 0.05) and correction for genomic inflation. A similar associ-
ation study was performed using the indel data, where inserts,
deletions, and wild types were coded as +1,1, and 0, respectively.
This identified 22 unique indels quantitatively associated with
toxicity and present in at least five strains.
Analysis of SNP–SNP epistatic interactions was performed
using the ‘‘epistasis’’ option in PLINK, which is based on linear
regression analysis and tests the inclusion of an interaction term
(into the regression equation) for statistical significance. Using
a cutoff value of P < 1 3 106, we identified a further 20 SNPs that
we included for the predictive model.
Predicting MRSA virulence
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Transposon insertions
Transposon insertion clones of USA300 were obtained from the
Nebraska Transposon Mutant Library (Fey et al. 2013).
Class-predictive model
From the total set of 122 SNPs and indels we then removed those
with identical ‘‘signatures’’ across the strains (see Supplemental
Fig. 4), leaving 50 unique SNPs/indels which we used to build
a class-predictive model. Due to the large number of free parame-
ters and relatively low number of samples (i.e., isolates) we chose
a random forest (Breiman 2001; Touw et al. 2013) approach, using
the randomForest package in R, which is an ensemble machine
learning algorithm based on decision trees. The benefit of this
method is that it naturally provides generalization error estimates
as well as variable importance, without the need for explicit cross-
validation procedures (as these are intrinsic to the method). For
class-prediction we categorized our isolates based on measured
toxicity into low (<40,000), medium (<63,000), and high. ‘‘Vari-
able Importance’’ is automatically calculated by the algorithm by
comparing, for each variable, the out-of-bag error rate for the final
model fit to one where the variable is permuted. Larger differences
therefore relate to higher importance.
Site-directed mutagenesis of AgrC and construction of
modified AIP/AgrC bioreporters
An agrP3Tlux bioreporter strain had previously been constructed
by replacing the entire agr locus in RN4220 with the erythromycin
resistance gene ermB and an agrP3TluxABCDE promoter fusion to
create ROJ48 (Jensen et al. 2008). A previously constructed plasmid
pAgrP2C1A, containing the agrP2 promoter, agrC, and agrA, was
then modified by site-directed mutagenesis to introduce either
the I311T AgrC amino acid substitution found in the TW20 line-
age, or both I311T and the A343T AgrC substitution conferred by
SNP2174068. Mutagenesis was performed using the phosphory-
lated primers shown in Table 2 and Phusion DNA polymerase
(New England Biolabs) before ligation of the resulting PCR prod-
ucts by Quick Ligase enzyme (New England Biolabs). ROJ48 was
then transformed with the modified plasmids to create mutant
bioreporters.
AIP/AgrC bioluminescent reporter assay
The bioreporter strains TJS114 and TJS120, containing one of the
mutated agrP2C1A plasmids, were grown overnight at 37°C in BHI
medium supplemented with 10 mg/mL chloramphenicol. Over-
night cultures were diluted 1:50 in fresh BHI before growth for
a further 2 h and then diluted 1:20 intowells of a 96-wellmicrotiter
plate containing triplicate serial dilutions of AIP-1 in BHI. The plate
was incubated in a Tecanmicroplate reader overnight and readings
taken for relative light units and OD600 every 15 min. The two
reporters with and without the A343T substitution were each
tested in triplicate. Data were plotted as relative light units per cell
density (RLU/OD) over time in Excel (Microsoft Corp.) and peak
values from each concentration of AIP were extracted. Data for
each reporter assay were normalized so that the RLU/OD at a sat-
urating AIP-1 concentration (1 mM) was 100 and then exported to
PRISM2 program (GraphPad). An EC50 value was then generated
for each reporter based on the variable slope sigmoidal dose re-
sponse curve.
In vivo murine infection models
Female NMRI mice of 6–8 wk of age were obtained from Charles
River Laboratories. Experiments were approved by the Animal
Research Ethical Committee of the University of Gothenburg.
S. aureus strains MU9 and HU13 were prepared for infection ex-
periments as described previously (Josefsson et al. 2008; Kenny
et al. 2009). Invasive infectionwas induced inmice by intravenous
injectionwith a lower dose of strainMU9 (3.73 107 CFU) or HU13
(4.1 3 107 CFU), or with a higher dose of strain MU9 (8.0 3 107
CFU) or HU13 (7.8 3 107 CFU). Survival, arthritic index, and
weight were monitored for 14 d. The overall condition of each
mouse was examined by assessing signs of systemic inflammation
such as weight decrease, reduced alertness, and ruffled coat. In
cases of severe systemic infection, when a mouse was judged too
ill to survive another 24 h, it was killed by cervical dislocation and
considered dead due to sepsis. Clinical evaluation of septic arthritis
was performed as describedbefore (Josefsson et al. 2008; Kenny et al.
2009). Differences between groups were examined for statistical
significance using the Logrank test at survival analysis, the Mann-
Whitney test at arthritic index analysis, or the Student’s t-test at
weight decrease analysis. Arthritic index andweight change data are
reported as medians, interquartile ranges, and 80% central range.
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